Safety & tolerability of bedaquiline & delamanid along with background regimen for treatment of Paediatric DRTB(RR)/MDR/Pre XDR/XDR TB) in children aged 6-18 years
Implementing Organization
National Institute of Tuberculosis & Respiratory Diseases, Delhi
Principal Investigator
Prof. S. Sharma
National Institute of Tuberculosis & Respiratory Diseases, Delhi